A 2003
survey, led
by Scott Kim, an associate professor in the bioethics program at the University of Michigan at Ann Arbor, showed that if participants were told that a researcher or institution testing a treatment was being funded
by the pharmaceutical
company that made the
drug, 40 percent would be more willing to participate — a finding Kim chalks up to an appreciation for up - front honesty.